Release Date: 22/10/12 09:10 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 77.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%